Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
Recruiting · NCT07513181 · Registry updated 2026-09-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC) | Digestive System Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, colitis, colonic disorder, digestive system disorder, gastroenteritis, immune system disorder, inflammatory bowel disease, intestinal disorder, ulcer disease, ulcerative colitis | Recruiting | Phase 2 | 2026-09-21 | NCT07513181 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Athos Therapeutics Inc | 1 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cleveland Clinic Foundation | Cleveland | United States | 370 |
| Gastroenterology Consultants, P.C. | Roswell | United States | 3 |
| GCP Clinical Research | Tampa | United States | 9 |
| Miami Clinical Research | Miami | United States | 7 |